← Leaderboards
Erich M Sturgis
University Of Tx Md Anderson Can Ctr
$2,392,613
Attributed
$4,259,442
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,259,442 · 3
By mechanism
U01$4,105,442 · 2
R03$154,000 · 1
Top collaborators
- Karen Sue Anderson3 shared
- Kristina Dahlstrom1 shared
- Ann Spolarich1 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Kathleen Schmeler$5,727,235
- Guojun Li$2,468,355
- Katherine Arnold Hutcheson$5,107,957
- Mitchell J. Frederick$5,632,139
- John Paul Christodouleas$1,684,168
Others in their field
Top investigators on “Serum”
- Joseph B. Margolick · Johns Hopkins University$72,041,404
- Monica M Bertagnolli · Strang Cancer Prevention Center$59,344,476
- Leonardo Trasande · New York University School Of Medicine$53,176,255
- Bradley F Boeve · Mayo Clinic Rochester$50,650,130
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$50,055,104
- Laurence H Baker · University Of Michigan At Ann Arbor$48,684,161
Research focus
SerumHuman Papillomavirus 16PrevalenceDetectionMalignant Neoplasm Of Cervix UteriCancer RecurrenceIncidencePeripheral BloodSuccessBloodSamplingFundingInfectionEnzyme-Linked Immunosorbent AssayEnrollmentFoundationsCancer PatientGeneral PopulationGeographic LocationsAntibodiesBiological MarkersControlled Clinical TrialsAdvanced DiseaseDesign
Grant awards (7)
Southwest EDRN Clinical Validation Center for Head and Neck Cancer$1,008,620
U01 · FY2025 · CA
HPV-related Oropharyngeal Cancer Screening and Monitoring through Remote Self-Sampling$678,031
U01 · FY2025 · DE · contact PI
Southwest EDRN Clinical Validation Center for Head and Neck Cancer$963,127
U01 · FY2024 · CA
HPV-related Oropharyngeal Cancer Screening and Monitoring through Remote Self-Sampling$707,991
U01 · FY2024 · DE · contact PI
Southwest EDRN Clinical Validation Center for Head and Neck Cancer$747,673
U01 · FY2023 · CA
Use of Serum HPV16 DNA as a Marker for Oropharyngeal Cancer Recurrence$77,000
R03 · FY2008 · CA · contact PI
Use of Serum HPV16 DNA as a Marker for Oropharyngeal Cancer Recurrence$77,000
R03 · FY2007 · CA · contact PI